HMGCR and Alzheimer disease: Hypercholesterolemia is an early risk factor for AD, while decreased prevalence of AD is associated with the use of cholesterol-lowering drugs (statins) that inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase [9–11].